Skip to main content
OpenTrials

Clinical trial condition

Prostate Cancer Metastatic

Explore clinical trials studying Prostate Cancer Metastatic. Study availability and eligibility vary by location and protocol.

85 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Prostate Cancer Metastatic trial results

Completed

Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT01718353

Conditions
Prostate Cancer Metastatic
Locations
  • Investigational Site Number 840003 Birmingham, Alabama, United States
  • Investigational Site Number 840102 Washington D.C., District of Columbia, United States
  • Investigational Site Number 840005 Indianapolis, Indiana, United States
  • Investigational Site Number 840025 Metairie, Louisiana, United States
View all 19 locations
View Trial Details
Completed

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

NCT01360840

Conditions
Prostate Cancer Metastatic
Locations
  • Research Site Pleasant Hill, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site New Orleans, Louisiana, United States
  • Research Site Ann Arbor, Michigan, United States
View all 71 locations
View Trial Details
Completed

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

NCT01254279

Conditions
Prostate Cancer Metastatic
Locations
  • Investigational Site Number 036004 Box Hill, Australia
  • Investigational Site Number 036020 Campbelltown, Australia
  • Investigational Site Number 036001 Camperdown, Australia
  • Investigational Site Number 036002 Camperdown, Australia
View all 165 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

NCT04848337

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • City of Hope Duarte, California, United States
  • Winship Cancer Instituted of Emory University Atlanta, Georgia, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Oregon health Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

NCT05067140

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations
  • Clinical Trial Site Duarte, California, United States
  • Clinical Trial Site Fresno, California, United States
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Northwestern Medicine Cancer Centers Warrenville, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions